The fourth generation AlereTM HIV Combo rapid test improves detection of acute infection in MTN-003 (VOICE) samples

Journal of Clinical Virology

Volumn 94, Issue , 2017, Pages 15-21

  Livant, Edward ^a   Heaps, Amy ^b   Kelly, Cliff ^c   Maharaj, Rashika ^d   Samsunder, Natasha ^e   Nhlangulela, Lindiwe ^f   Karugaba, Patrick ^g   Panchia, Ravindre ^h   Marrazzo, Jeanne ^i,k   Chirenje, Zvavahera Mike ^j   Parikh, Urvi M ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c SCHARP   (United States)

^d HIV Prevention Research Unit   (South Africa)

^e UNIVERSITY OF KWAZULU NATAL   (South Africa)

^f AURUM INSTITUTE   (South Africa)

^g MU JHU Research Collaboration   (Uganda)

^h UNIVERSITY OF THE WITWATERSRAND   (South Africa)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

^j UZ UCSF   (Zimbabwe)

^k UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

more..

Author keywords

4th generation rapid test; Acute infection; HIV confirmatory test; HIV diagnostics; HIV 1; Pre exposure prophylaxis

Indexed keywords

VIRUS RNA; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ACUTE HIV INFECTION; ARTICLE; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; FEMALE; HIV RAPID TEST; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PREDICTIVE VALUE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY AND SPECIFICITY; SEROCONVERSION; SOUTH AFRICA; UGANDA; WESTERN BLOTTING; ZIMBABWE; BLOOD; CLINICAL TRIAL; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; IMMUNOLOGY; ISOLATION AND PURIFICATION; PHASE 2 CLINICAL TRIAL; PRE-EXPOSURE PROPHYLAXIS; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; SEROLOGY; STANDARDS; VIROLOGY;

HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOASSAY; PRE-EXPOSURE PROPHYLAXIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; VIROLOGY;

EID: 85023193338     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2017.06.006     Document Type: Article

References (17)

1. Parikh, U.M., Mellors, J.W., Should we fear resistance from tenofovir/emtricitabine preexposure prophylaxis?. Curr. Opin. HIV AIDS 11:1 (2016), 49–55.
2. WHO, Service Delivery Approaches to HIV Testing and Counselling (HTC): a Strategic HTC Programme Framework. 2012, World Health Organization, Geneva http://apps.who.int/iris/bitstream/10665/75206/1/9789241593877_eng.pdf.
3. Patel, P., et al. Rapid HIV screening: missed opportunities for HIV diagnosis and prevention. J. Clin. Virol. 54:1 (2012), 42–47.
4. ® HIV-1/2 Ag/Ab combo test. J. Infect. Dis. 205:4 (2012), 528–534.
5. Duong, Y.T., et al. Poor performance of the determine HIV-1/2 Ag/Ab combo fourth-generation rapid test for detection of acute infections in a National Household Survey in Swaziland. J. Clin. Microbiol. 52:10 (2014), 3743–3748.
6. Kilembe, W., et al. Failure of a novel, rapid antigen and antibody combination test to detect antigen-positive HIV infection in African adults with early HIV infection. PLoS One, 7(6), 2012, e37154.
7. Fox, J., Dunn, H., O'Shea, S., Low rates of p24 antigen detection using a fourth-generation point of care HIV test. Sex. Transm. Infect. 87:2 (2011), 178–179.
8. Faraoni, S., et al. Evaluation of a rapid antigen and antibody combination test in acute HIV infection. J. Clin. Virol. 57:1 (2013), 84–87.
9. Masciotra, S., et al. Performance of the Alere Determine HIV-1/2 Ag/Ab Combo rapid test with specimens from HIV-1 seroconverters from the US and HIV-2 infected individuals from ivory coast. J. Clin. Virol. 58:Suppl 1 (2013), e54–8.
10. Beelaert, G., Fransen, K., Evaluation of a rapid and simple fourth-generation HIV screening assay for qualitative detection of HIV p24 antigen and/or antibodies to HIV-1 and HIV-2. J. Virol. Methods 168:1–2 (2010), 218–222.
11. Vetter, B.N., et al. Generation of a recombinant Gag virus-like-particle panel for the evaluation of p24 antigen detection by diagnostic HIV tests. PLoS One, 9(10), 2014, e111552.
12. Fitzgerald, N., et al. Diagnosing acute HIV infection at point of care: a retrospective analysis of the sensitivity and specificity of a fourth-generation point-of-care test for detection of HIV core protein p24. Sex. Transm. Infect., 93, 2016.
13. Marrazzo, J.M., et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N. Engl. J. Med. 372:6 (2015), 509–518.
14. Stekler, J.D., et al. Performance of Determine Combo and other point-of-care HIV tests among Seattle MSM. J. Clin. Virol. 76 (2016), 8–13.
15. Smallwood, M., et al. Evaluation of a rapid point of care test for detecting acute and established HIV infection, and examining the role of study quality on diagnostic accuracy: a Bayesian meta-analysis. PLoS One, 11(2), 2016, e0149592.
16. Lanzafame, M., et al. Performance of Alere Determine HIV-1/2 Ag/Ab Combo rapid test for acute HIV infection: a case report. Infez. Med. 23:1 (2015), 48–50.
17. Chetty, V., Moodley, D., Chuturgoon, A., Evaluation of a 4th generation rapid HIV test for earlier and reliable detection of HIV infection in pregnancy. J. Clin. Virol. 54:2 (2012), 180–184.